Trial intelligence / Profile preview

Ondansetron versus dexamethasone for prevention of post-spinal anesthesia hypotension in elderly urologic surgery patients

IRCT20230513058164N1Phase 3Completed

Sponsor
Yasouj University of Medical Sciences
Start
Nov 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of ondansetron and dexamethasone in hypotension and bradyarrhythmia (3 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 3 more. Started Nov 2022; status: completed.

02

Drugs

ondansetrondexamethasone
03

Conditions

hypotensionbradyarrhythmia

Beyond the preview

Go deeper on IRCT20230513058164N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230513058164N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call